Study Analyzing Implied Preferences for Gadolinium Properties in Patients Undergoing Breast MRI

Overview

About this study

The purpose of this study is to measure the part-worth utilities breast MRI screening patients place on different MRI gadolinium contrast parameters, and to use those data to better understand and deliver patient-centered contrast agents for MRI screening exams.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adult women scheduled to undergo a clinically-indicated breast MRI exam.
Women with a personal history of breast cancer or high or immediate risk factors for breast cancer, including:
- BRCA1 mutations, BRCA2 mutations, and other mutations that confer high risk;
- Untested first degree relatives of patients with mutations conferring high risk;
- History of chest radiation between ages 10 and 30;
- History of atypical ductal hyperplasia (ADH), atypical lobular neoplasia (ALH), or lobular carcinoma in situ (LCIS)”.

Exclusion Criteria:

Inpatients.
Pediatric patients.
Patients who are unable to provide consent.
Patients who cannot compete the survey.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Jennifer McDonald, Ph.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Jennifer McDonald, Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials